BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9166483)

  • 1. Does adjuvant radiation therapy hold promise for improved outcome in advanced Hodgkin's disease?
    Mauch P
    Cancer J Sci Am; 1995; 1(4):247-9. PubMed ID: 9166483
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Stage IIIa Hodgkin's disease: long follow-up perspective.
    Lister TA
    J Clin Oncol; 2008 Nov; 26(32):5144-6. PubMed ID: 18854554
    [No Abstract]   [Full Text] [Related]  

  • 3. Don't throw out the baby with the bathwater: on optimizing cure and reducing toxicity in Hodgkin's lymphoma.
    Yahalom J
    J Clin Oncol; 2006 Feb; 24(4):544-8. PubMed ID: 16446326
    [No Abstract]   [Full Text] [Related]  

  • 4. [Novel approaches to combination therapy of Hodgkin's disease].
    Kharchenko VP; Pan'shin GA; Datsenko PV; Sotnikov VM; Mel'nik IuD
    Vopr Onkol; 2005; 51(6):692-6. PubMed ID: 17037037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of combined treatment of stage III(B) Hodgkin's disease].
    Kanaev SV; Golovanov SG; Girshovich MM; Gershanovich ML
    Vopr Onkol; 2006; 52(5):525-30. PubMed ID: 17168360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategies for the treatment of early stages of Hodgkin's lymphoma.
    Macdonald DA; Connors JM
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):871-80. PubMed ID: 17908625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is irradiation of intact ileoinguinal lymph nodes necessary in radiochemotherapy for stage-III Hodgkin's disease?].
    Kanaev SV; Girshovich MM; Golovanov SG; Gershanovich ML
    Vopr Onkol; 2007; 53(4):453-5. PubMed ID: 17969410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary treatment of early stage Hodgkin's disease].
    Molnár Z; Esik O; Illés A
    Orv Hetil; 2005 Jan; 146(2):57-61. PubMed ID: 15724953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-stage favorable Hodgkin's lymphoma: is chemotherapy alone sufficient?
    Ozsahin M; Ozsahin H
    J Clin Oncol; 2010 Nov; 28(32):e668-9; author reply e670. PubMed ID: 20713868
    [No Abstract]   [Full Text] [Related]  

  • 11. [Medicinal therapy of malignant lymphomas].
    Aul C; Schroeder M; Giagounidis A
    Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New strategies for the treatment of advanced-stage Hodgkin's lymphoma.
    Diehl V; Engert A; Re D
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):897-914. PubMed ID: 17908627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of efficacy of chemoradiotherapy for Hodgkin's disease].
    Kanaev SV; Gershanovich ML; Pozharisskiĭ KM; Girshovich MM; Malinin AP; Golovanov SG
    Vopr Onkol; 2004; 50(6):652-7. PubMed ID: 15755057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy and radiotherapy in Hodgkin's lymphoma: joining in or splitting up?
    van der Maazen RW; Raemaekers JM
    Curr Opin Oncol; 2006 Nov; 18(6):660-6. PubMed ID: 16988591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].
    Kuleva SA
    Vopr Onkol; 2008; 54(6):768-70. PubMed ID: 19241857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined modality treatment of Hodgkin's lymphoma.
    Klimm B; Engert A
    Cancer J; 2009; 15(2):143-9. PubMed ID: 19390310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the optimal treatment volume in Hodgkin's disease patients undergoing high-dose chemotherapy and adjuvant radiation therapy?
    Mundt AJ; Connell PP; Mansur DB
    Radiat Oncol Investig; 1999; 7(6):353-9. PubMed ID: 10644058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse of Hodgkin's disease after 10 years of complete remission: case report.
    Mwanda OW; Othieno-Abinya N
    East Afr Med J; 1998 Mar; 75(3):192-4. PubMed ID: 9640822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
    Hudson MM; Krasin M; Link MP; Donaldson SS; Billups C; Merchant TE; Kun L; Billet AL; Kaste S; Tarbell NJ; Howard S; Friedmann AM; Hurwitz CA; Young JA; Marcus KC; Rai S; Cowan T; Weinstein HJ
    J Clin Oncol; 2004 Nov; 22(22):4541-50. PubMed ID: 15542805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.